• Thumbnail for Novavax
    39°08′14″N 77°13′36″W / 39.1371°N 77.2267°W / 39.1371; -77.2267 Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland...
    31 KB (2,834 words) - 17:51, 4 April 2024
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    65 KB (4,734 words) - 04:34, 31 March 2024
  • Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO:...
    318 KB (19,351 words) - 20:33, 14 March 2024
  • Institute of India has also reached an agreement with Novavax for the production of Novavax's NVX-CoV2373 (Covovax) vaccine for India and other low and...
    19 KB (1,601 words) - 21:04, 11 February 2024
  • Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of February 19, 2023, 166,423,405 total vaccine doses have been administered...
    99 KB (8,592 words) - 07:13, 26 March 2024
  • Indian-American vaccinologist who leads vaccine development at Novavax. She oversaw the development of the Novavax COVID-19 vaccine. Patel was born in Sojitra, a farming...
    6 KB (688 words) - 06:39, 29 November 2023
  • initially teamed with Novavax Inc., a bio-technology company also based in Gaithersburg, MD., in the development and manufacture of the Novavax COVID-19 vaccine...
    69 KB (7,277 words) - 13:58, 11 February 2024
  • Thumbnail for Quillaja saponaria
    224-233. doi:10.1007/s12026-018-8991-x Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial. Novavax Press Release, Jan 28, 2021. https://ca...
    8 KB (853 words) - 21:14, 12 March 2024
  • Thumbnail for SARS-CoV-2 Beta variant
    2021. Retrieved 20 March 2021. "Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial". ir.novavax.com. 28 January 2021. Archived from...
    72 KB (6,070 words) - 06:39, 3 February 2024
  • Thumbnail for South Korea
    through the COVAX facility under the WHO hospice. A recent agreement with Novavax expands its production for a second vaccine to 40 million doses in 2022...
    276 KB (24,982 words) - 18:02, 16 April 2024